S. Horisawa
Sumitomo Pharmaceuticals Co.
Ltd. Research Center
Osaka
Japan
Name/email consistency: high
- Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia. Horisawa, S., Kaneko, M., Sakurama, T. Thromb. Res. (2001)
- Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs. Horisawa, S., Kaneko, M., Ikeda, Y., Ueki, Y., Sakurama, T. Thromb. Res. (1999)
- SM-20302, a nonpeptide GPIIb/IIIa receptor antagonist, exhibits a wide therapeutic window in a newly developed hemorrhage model in mice. Horisawa, S., Kaneko, M., Sakurama, T. Thromb. Haemost. (1999)